Trial Number

323-22

Participant Age Range

6 years to 12 years

Participant Gender

Any

Enrolling Participants

Yes

Overview

“Phase 1/2 Study of Switching to Fixed Dose Combination Dolutegravir/Rilpivirine among Virologically Suppressed Children 6 to less than 12 Years of Age, Living with HIV-1”

Study of switching to fixed dose treatment in children living with HIV-1

Provider

Jagmohan S Batra, MD

Infectious Disease - Pediatric
Long Beach
View Profile

Location

Miller Children’s & Women’s Hospital Long Beach

2801 Atlantic Avenue
Long Beach
(562) 933-5437
Location Details

Related Clinical Trials

Click on the category you are interested in.

Pediatric Care Miller Children's & Women's Hospital Long Beach
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.